Imanib 400mg Imatinib Tablet

Imanib 400mg Imatinib Tablet is a prescription targeted anti-cancer medication used in the treatment of chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), gastrointestinal stromal tumors (GISTs), and certain other cancers. It contains Imatinib, a tyrosine kinase inhibitor (TKI) that works by blocking specific proteins responsible for the growth and spread of cancer cells. By targeting these abnormal cellular pathways, Imanib 400mg Imatinib Tablet helps slow disease progression and supports effective long-term cancer management. Taken orally under the supervision of an oncology specialist, it requires regular monitoring to evaluate treatment response and manage potential side effects. Patients should use Imanib 400mg Imatinib Tablet only as prescribed by their healthcare provider and follow all recommended medical appointments during therapy.